MSD Ireland – Our sites
As you can see our operations are based throughout Ireland, with our sites located in Carlow, Cork, Dublin, Meath and Tipperary.
MSD Ballydine
First established in 1976, MSD Ballydine develops and supplies the active ingredients and final formulated product for a range of innovative medicines at its manufacturing and R&D facilities. MSD’s first site in Ireland, the Ballydine site is MSD’s primary small molecule pipeline commercialisation facility globally, operating as a European hub for quality, manufacturing, and engineering. Its highly skilled teams leads the way in the development of new medicines, including innovative treatments for Hepatitis C, HIV and immuno-oncology, the site exports to over 25 countries around the world.
MSD Biotech, Dublin
MSD Biotech, Dublin began construction in 2018 and has progressed at an impressive rate since then. The site plays a pivotal role in the manufacture of MSD’s biologics-based medicines, including immuno-oncology, and it has expanded MSD’s current internal network of biologics drug substance manufacturing plants since full manufacturing operations began in 2021.
MSD Brinny
Our site in Brinny, Co. Cork has been a vibrant part of the pharmaceutical sector in the South-West region for 40 years. With a successful legacy of developing and commercially supplying biotech products including some of MSD’s most successful treatments for Oncology, Hepatitis C, and Rheumatoid Arthritis, Brinny is now specialising in the development and manufacture of innovative novel vaccines and testing of immuno-oncology medicines.
MSD Carlow
The MSD Carlow site broke ground in 2008 and is a filling site for the launch and commercial supply of vaccines, biologics and small molecule drug product. Since its initial launch, the site has attracted significant internal investment and is now home to a number of state of the art production facilities, laboratories and temperature controlled warehousing units. The Carlow site is a significant employer in the South East region and attracts high performing talent through close collaborations with universities and colleges in the region.
MSD Dunboyne
MSD Dunboyne joined our network in September 2020. Our Dunboyne site is MSD’s first Biologics Drug Substance Single Use Commercialisation Facility, playing an important role in helping to commercialise key medicines as the newest addition to the MSD network. The cutting-edge innovation and collaboration between MSD Dunboyne’s research and manufacturing teams will significantly accelerate the time it takes to bring a medicine to market for the benefit of patients around the world.
MSD Dundalk
The latest addition to the MSD Ireland network is MSD Dundalk. As a cutting-edge, state-of-the-art vaccines facility spanning over 15,500 square metres across three stories, MSD Dundalk will focus on qualification, continued product development, and expanding its capabilities within our network. Featuring drug substance manufacturing, drug product manufacturing, and quality control labs that will support the global supply of vaccine products – strengthening our ability to make an impact on people and patients worldwide by adding new capabilities to our already industry-leading network.
MSD Red Oak North
Red Oak North in Dublin is our commercial Head Office for our Animal Health and Human Health businesses in addition to several global and national support services including Clinical Research, Medical Affairs, Regulatory Affairs, Sales, Policy & Communications and Marketing.
MSD Animal Health Blackrock
MSD Animal Health Blackrock in Dublin is a global hub for our DNA TraceBack® and DataLive™ platforms and key support services, including DNA TraceBack®, Genomics & Food Diagnostics Laboratories, Product Development, R&D, Animal Data Science, Data Strategy & Integrations, Customer Success, Business Development, Finance, and Marketing. Serving markets globally, Blackrock drives farm-to-table traceability and advances data innovation and insights for a sustainable food supply.
